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Abstract 
Novel emerging drugs of abuse, also referred as new psychoactive substances (NPS), 
constitute an ever-changing mixture of chemical compounds designed to circumvent legislative 
controls by means of chemical modifications of previously banned recreational drugs. One of 
such class, synthetic cathinones, namely β-keto derivatives of amphetamines, has been largely 
abused over the past decade. A number of new synthetic cathinones are detected each year, either 
in bulk powders/crystals or in biological matrices. It is therefore important to continuously 
monitor the supply of new synthetic derivatives and promptly report them. By using 
complementary analytical techniques (i.e. 1D and 2D NMR, FT-IR, GC-MS, HRMS and HPLC-
UV), this study investigates the detection, identification and full characterization of 1-(4-
methylphenyl)-2-(methylamino)-pentanone (4-methyl-pentedrone, 4-MPD), 1-(4-fluorophenyl)-
2-(pyrrolidin-1-yl)-hexanone (4F-PHP) and 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-
pentanone (bk-EPDP), three emerging cathinone derivatives. 
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Introduction 
The emergence and propagation of new psychoactive substances (NPS), also known as ‘legal 
highs’ or ‘designer drugs’, is an expanding worldwide problem.[1, 2] Designed and synthesised to 
reproduce the effects of traditional illicit substances such as cannabis, stimulants and 
hallucinogens, they are widely available in many countries for purchase online.  
Synthetic cathinones constitute a class of NPS which have had an increased demand over the 
past few years following the introduction of mephedrone to the illicit market. Like other NPS, to 
evade seizures under local drug legislations, various analogues of synthetic cathinones can be 
synthesised with modifications to circumvent the legal restrictions. New products are often 
purposely labelled with just the chemical abbreviation or, in some cases, marketed without any 
ingredient information or intentionally declared different from actual composition. Hence, 
effective and reliable analytical methods used to accurately identify the structure of new 
cathinone derivatives, together with constant monitoring of market availability are important. 
They serve as first step to identify new compounds which can then lead on to further studies of 
their health risks when consumed recreationally.[2] Data from different spectroscopic techniques 
coupled to mass spectrometry are often used in a complementary fashion in order to characterise 
and confirm unknown structures, particularly in cases where suitable reference material does not 
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exist or where the compounds are novel and unknown.[3-7] This approach of using uncorrelated 
analytical methods is recommend by the Scientific Working Group for the Analysis of Seized 
Drugs (SWGDRUG).[8] 
In this work, the detection and identification of three suspected samples containing 
cathinones were carried out (1–3, Figure 1). The samples were obtained from TICTAC 
Communications Ltd and were test purchased online from an overseas, open access website as 
NPS prior to the May 2016 Act. Based on their labels, these samples were assumed to belong to 
the cathinone drug class. However, their compositions and purity were indeterminate. The labels 
of each sample used were abbreviated as 4-MPD (1), 4F-PHP (2) and bk-EPDP (3). Analytical 
reports of compounds 1-3 have been recently reported to the European Monitoring Centre for 
Drugs and Drug Abuse (EMCDDA) early warning system (EWS) on new psychoactive 
substances, to the European Project Response [9-12], and to the Scientific Working Group for the 
Analysis of Seized Drugs (SWGDRUG) [13]. Compound 1, 1-(4-methylphenyl)-2-(methylamino)-
pentanone  (i.e. 4-methyl-pentedrone, 4-MPD), compound 2, 1-(4-fluorophenyl)-2-(pyrrolidin-1-
yl)-hexanone   and compound 3, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone, have 
been recently reported by TICTAC Communications Ltd and King’s College London to the UK 
Focal Point (the UK reporting agency for EWS) as compounds new to the UK. 
 
Experimental  
Reagents and Samples 
Methanol, acetonitrile, water, formic acid (FA) and trifluoroacetic acid (TFA), HPLC grade, 
dimethyl sulfoxide-d6 and isotopic purity 99.9 atom %D were purchased from Sigma-Aldrich 
(Dorset, UK). Methanol (LC-MS grade), t-butyl-methyl-ether (TBME), tripelennamine, 
quinolone were from Sigma-Aldrich (Dorset, UK). Deuterium oxide, isotopic purity 99.8 atom 
%D, was purchased from Fluorochem LTD (Derbyshire, UK). Three unknown street samples 
were received from TICTAC Communications Ltd (London, UK). The samples were test 
purchased as NPS from an overseas, open access website. Samples were kept in a locked cabinet 
at room temperature.  
 
Sample Preparation 
Stock solutions 1 mg/mL of each sample were prepared in methanol, and then samples were 
filtered with polypropylene (PP) syringe filters (pore size 0.2 µm). Stock solutions were stored at 
-20 oC. 
Sample preparations for HPLC-DAD analysis were prepared at concentration of 0.1 mg/mL 
with HPLC mobile phase (50:50 (v/v) water:acetonitrile containing 0.1% TFA). PP syringe 
filters, pore size 0.2 µm, were used to filter the samples before injecting them into the HPLC 
instrument. 
Sample preparations for the HRMS analysis were prepared at the concentration of 1µg/mL in 
a 50:50 (v/v) water:methanol containing 0.1% FA. PP syringe filters, pore size 0.2 µm, were 
used to filter samples prior to MS analysis. 
Samples for NMR spectroscopy analysis were dissolved in deuterated solvents. Solutions 
were filtered through PP syringe filters. 
Sample preparation for GC-MS analysis was 1 mL of methanol added to 1.5 mL 
polypropylene tubes (Appleton Woods, Birmingham, UK) containing approximately 100 mg 
powder which was then vortexed for at least 30 minutes before being centrifuged at 6,030 g for 1 
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minute. An aliquot of 10 µL was diluted with 1 mL of TBME, containing 100 µg/mL each of 
quinoline and tripelennamine as the internal standards. 
 
Analytical Instrument Conditions 
HPLC-DAD: a HP 1050 series was used equipped with a quaternary pump, an auto-sampler, 
a diode array detector (DAD) and a Kontron DEG 104 degasser. Agilent ChemStation software 
was used to control the equipment. A C8 kinetex® column 100×2.1 mm i.d., particle size 5 µm 
was purchased from Phenomenex Inc. HPLC mobile phases A and B consisted of 0.1% v/v TFA 
in water and acetonitrile, respectively. The gradient was 0% B ramping to 90% B within 20 
minute. The flow rate was set at 0.2 mL/min and the injection volume was 5 µL. 
HRMS: a Thermo Scientific™ Exactive™ Plus EMR mass spectrometer was employed with 
flow-injection-analysis mode (a zero dead volume connector replaced the HPLC column) at 
0.2mL/min using 50% B: 50% A where A is water in 0.3% FA and B is acetonitrile in 0.3%FA. 
NMR spectroscopy: a Bruker Avance DRX 400 MHz NMR spectrometer was used 
employing solvent residual peaks as internal standards. 
GC-MS: the samples were qualitatively analysed using an Agilent 7890A GC with 5975C 
VL MSD (Santa Clara, California, USA) equipped with a split-splitless injector and an HP5-MS 
column (30 m length, 0.25 mm internal diameter, 0.25 µm film thickness) and running on 
Agilent ChemStation software. 1 µL of the extract was injected using 5:1 split ratio. The column 
was held at 80°C for 4 minutes and then ramped up at 40°C/min to 290°C and held to a total run 
time of 19.25 minutes. A mass range of m/z 40 to 400 was scanned. 
FT-IR: all powders were analysed on the Bruker Alpha (Platinum ATR; Coventry, UK) IR 
instrument that uses a diamond to achieve attenuated total reflection (ATR) as the mode of 
action. A spatula tip of powdered sample was directly loaded onto the FTIR instrument for 
analysis following a background scan. 
 
 
Results and discussion 
Classifying samples as the cathinone drug class 
The chemical structures of the three synthetic cathinones are presented in Figure 1.  Following 
analytical investigation via GC-MS, FT-IR, tandem MS and NMR we concluded that full 
structural elucidation of these compounds was not previously reported in any scientific paper to 
the best of our knowledge.  
 
FIGURE 1 ABOUT HERE 
 
Figure 1. Chemical structures of the cathinones detected in the analysed samples. 
 
 
The suspected samples were initially screened via FT-IR for the presence of synthetic 
cathinones, rather than other chemical types of legal highs such as tryptamines, synthetic 
cannabinoids, phenylethylamines or piperazines. For the cathinone drug class, the functional 
groups of cathinone is displayed in a spectra as the carbonyl stretching conjugated with phenyl 
group showing the characteristic absorption at 1700-1680 cm-1. The broad spectrum from 3100-
2200 cm-1 can be defined as the C-H stretching and the absorption from the amine salt if present 
in this form.[14] Thus, considering the FTIR spectrum of the three samples (Supporting 
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Information, Section S2), the cathinones characteristics were shown very clearly. IR spectra of 
the three emerging cathinones 1-3 appear identical to the ones illustrated in recent analytical 
reports. [9-13] 
 
 
 
HPLC-DAD analysis 
Reverse phase liquid chromatography with a C8 column was chosen to separate the cathinone 
component from any other impurities; the use of multiple wavelengths in the UV region allowed 
for any UV-absorbing impurity (typical of most NPS) to be examined. Five wavelengths in a 
range of 214 – 281 nm were set for detecting samples. With the same analytical conditions, 
samples were eluted at retention times ranging from 12.5 to15.1 minutes. There were no distinct 
impurity peaks in the chromatograms at any wavelengths operated, thus, samples were 
considered to be pure in terms of NPS content. HPLC-DAD chromatograms of all the samples 
are illustrated in Figure S5-1 (Supporting Information). 
 
GC-EI-MS analysis  
The total ion current (TIC) chromatogram of all samples showed some very minor impurities and 
also the sharp and distinct main peak of the suspected cathinones. The EI mass spectrum of the 
main peak showed an immonium ion as the dominant base peak for all samples (see supporting 
information, Section S1). GC-MS spectra were in agreement with those recently reported by 
Cayman Chemical [15-17]. 
 
NMR Analysis 
Table 1 presents a summary of NMR spectroscopic results, including skeleton connectivity 
evidences obtained from HSQC, HMBC and COSY analyses (see also section S3, supporting 
information) of the three new cathinones. Beside us having reported NMR data for such new 
cathinones to the EMCDDA EWS, few other analytical reports have recently appear, illustrating 
the 1H and 13C NMR of compounds 2-3 [10-12], as well as bidimensional NMR spectra for 
compound 6. No NMR data for compound 1 was however reported, nor any bidimensional 
spectra for compound 2, which are presented in this work. In addition, to further complement the 
analytical properties of the new cathinone derivatives, we also present DEPT experiments of 
these derivatives. 
 
 
 
TABLE 1 
 
 
 
HRMS  
The chemical structures identified by NMR analysis were further consolidated using HRMS 
(Table 2). The exact masses of all the compounds match the predicted theoretical values with 
errors being less than 3 ppm.  
 
 
TABLE 2 
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FIGURE 2 ABOUT HERE 
 
Figure 2. COSY and HMBC correlations: (a) compound 1; (b) compound 2; and (c) compound 
3. 
 
 
Identification of 1-(4-methylphenyl)-2-(methylamino)-pentanone (compound 1):  
Based on the structural elucidation using the NMR technique, compound 1 was identified as 
1-(4-methylphenyl)-2-(methylamino)-pentanone (4-methyl-pentedrone). In the aromatic region 
of the 1H NMR, the splitting pattern shows the characteristic pattern of para-substituent benzene 
rings (i.e. ‘roof effect’). From the 1H spectrum, there were eight types of H-signal. The 2D NMR 
data revealed that the substituent at the alpha carbon position was an n-propyl group. The 1H 
splitting pattern, HSQC and the chemical shift of carbons at the benzene skeleton confirmed the 
presence of methyl group substituent in para-position. Figure 2a illustrates the HSQC, COSY 
and HMBC correlations of compound 1’s structure. 4-methyl-pentedrone can be classified as an 
N-monoalkyl cathinone. Pozo et al. [18] have described the ESI fragmentation mechanism of the 
N-containing drugs (mephedrone) where the rearrangement might occur via formation of an 
indole ring if the loss of an amine group could not be found. In our work, the proposed 
mechanism shows that distinct product ions (fragments a-g, Figure S4-4) can be produced via an 
indole ring formation or an alkyl side chain loss fragmentation pathway. Indeed, in-house 
analysis of a deuterated standard of the synthetic cathinone mephedrone indicated that the indole 
ring pathway is preferred (Figure S4-2). This is in agreement with the findings of Pozo et al.[18] 
The base peak, with m/z 145.0885, derives from the loss of water, followed by propyl radical loss 
at the alpha carbon. Other product ions, such as the loss of ethane or propane at m/z 158.0963 
and 144.0806, were also detected. An alkyl loss at N-position was finally observed at m/z 
130.0650. The two proposed fragmentation pathways of compound 1 are shown in Figure S4-4 
(Supporting Information). The molecular structure of compound 1 was also confirmed by the 
GC-EI-MS spectrum. As can be seen in Table S1 and Figure S1-1, the data revealed the base 
peak of compound 1 having m/z = 86.2, which conforms to the m/z value of the proposed 
immonium ion of compound 1 (C5H12N+). 
 

Identification of 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)-hexanone (compound 2): 
Complete elucidation has shown that this compound is 1-(4-fluorophenyl)-2-(pyrrolidin-1-
yl)-hexanone. The 19F spectrum shows a distinct peak at the chemical shift = -102.9 ppm (see 
supplementary information, Figure S3-13). The fluorine atom may influence 1H and 13C spectra 
of compound 2, resulting in the 13C chemical shift of the benzene ring downfield (Table 1). The 
1H spectrum, at the aromatic region, shows doublet of doublets peaks at δ 8.21 and 7.47 resulting 
from four and three bonds couplings by the F atom. Thus, compound 2 is an aromatic fluorine-
containing atom placed in para position. The 1H NMR spectrum also shows the overlapped peaks 
between the hydrogen atoms from the methylene groups at the five-membered ring (position 
3″and 4″) and the hydrogen atoms from the long chain alkyl group (position 3) (Table 1). 
However, from HSQC, these protons can be differentiated as the spectrum reveals they are 
attached to the different carbon atoms. Hence, the six protons that appeared can be classified into 
two types, firstly, two protons of the butyl group at the alpha carbon side chain (-CH2-CH2-CH2-
CH3, position 3). Secondly, four protons of the pyrrolidine ring (position 3″and 4″). At position 4 
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and 5 in the 1H spectrum, the protons are also overlapped with each other. From 2D NMR data 
and the 13C chemical shift, these protons can be classified as the members of a butyl group but 
are different in the attached carbon (-CH2-CH2-CH2-CH3). Figure 2b shows COSY and HMBC 
correlations of compound 2’s structure. The fragmentation pathway of compound 2 is shown in 
Figure S4-6 (Supporting Information). A loss of the pyrrolidine ring is a favourable pathway for 
this type of cathinones. Thus, the distinct fragment observed in the ESI-HRMS/MS were m/z = 
109.0447 (Figure S4-6, fragment a). The cleavage between the alpha carbon and the carbonyl 
carbon producing an immonium ion or a benzoyl cation (Figure S4-6, fragments d and b) has 
also been detected. The immonium ion (140.1432) is identical to the based peak obtained from 
GC-EI-MS spectrum (Table S1). 


Identification of 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone (compound 3):  
The proton NMR spectrum of this compound shows the pattern of one doublet of doublets 
and two doublets peaks in the aromatic area derived from three different types of protons 
(position 6ˈ, 2ˈ, 5ˈ), as well as an acetal proton (-O-CH2-O-) signal at 6.09 ppm, which can 
confirm the existence of 3,4-methylenedioxy substituent group on the benzene ring. Other 
evidence such as the chemical shift of the acetal carbon at 102.6 ppm was observed (position 8)́ 
in the 13C spectrum. Ten types of protons were found in this compound’s 1H spectrum. The 2D 
NMR (Figure 2c) revealed that the substituent at the alpha carbon position was an n-propyl 
moiety. The complete elucidation has shown this compound to be 1-(1,3-benzodioxol-5-yl)-2-
(ethylamino)-1-pentanone (bk-EPDP). Bk-EPDP (compound 3) can be classified as 3,4-
methylenedioxy and N-monoalkylcathinone. The possible fragmentations of this kind of 
cathinone were the loss of water, the loss of CH2O from the 3,4-methylenedioxy group, CO loss 
that followed water loss and the loss of methyl radical.[19, 20] For the N-monoalkyl cathinone 
subclass, we detected the fragments resulting from the loss of amine groups at m/z 135.0438 and 
149.0231 (Figure 3a, peak d, e). However, the rearrangement via an indole ring may also be 
found. Based on the proposed fragmentation pathways of 4-MPD and deuterated mephedrone 
(Supporting Information), the proposed fragmentation pathway of compound 3, presented in 
Figure 3b, occurs via indole-ring formation. The product ion spectrum of compound 3 shows 
several fragment ions since, apart from the carbonyl side chain fragmentation, the molecule can 
also experience the loss of CH2O from 3,4-methylenedioxy group. The EI-MS of compound 3 
shows the immonium ion at the m/z 100.2 (Table S1) as the base peak, obtained from the 
dissociation between the alpha and beta carbon bond. Furthermore, the characteristic peaks in 
GC-EI-MS spectra suggest the presence of 3,4-methylenedioxy substituent benzene ring at m/z 
121.1 and 149.1 were also identified (see supporting information, Figures S1-3). 
 

FIGURE 3 ABOUT HERE
 
Figure 3. A) The product ion spectrum and B) the proposed fragmentation pathway of 
compound 3 
 
 
 
7 

Conclusion 
This work discloses the detection and structural identification of three emerging cathinone 
derivatives which were available on the web. While comparison of a reference material is 
desirable to confirm structural match, this is not always possible due to the lack of commercially 
available reference standards at the time of investigation. Chemical synthesis can be adopted to 
prepare in-house standards,[3, 4] however the use of multiple analytical tools can be a viable 
alternative to claim accurate structural elucidation. The purchased powders appeared highly pure, 
thus the characterised compounds could potentially be accepted as reference standards for 
routine tests by forensic laboratories. However, absolute quantitative analysis would need to be 
performed by means of e.g. accurate elemental analysis to establish the degree and amount of 
potential trace impurities and/or inorganic diluents. 
No toxicological data are available for such novel compounds, which presents a potential risk to 
human health. Thus, the analytical data given here can assist clinical/forensic toxicology 
laboratories by helping identify these compounds in biological samples and bulk powders.  
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Table 1. NMR data of the synthetic cathinones 1-3 
Sample ID 
1H 13C (DEPT) Connectivity correlation 
HSQC correlation, ppm COSY HMBC† 
 
  4-MPD (1) 
 
1 - 196.8 - 2ˈ, 6ˈ 
2 5.10 63.5 (+) 3 3, 4, 2″ 
3 1.94-2.01 32.0 (-) 2, 4 2, 5 
4 1.13-1.38 17.0 (-) 3, 5 2, 5 
5 0.82 12.8 (+) 4 3, 4 
1ˈ - 130.5 - 3ˈ, 5ˈ 
2ˈ, 6ˈ 7.91 129.0 (+) 3ˈ, 5ˈ, 7ˈ 1, 3ˈ, 4ˈ, 5ˈ 
3ˈ, 5ˈ 7.43 129.8 (+) 2ˈ, 6ˈ, 7ˈ 1ˈ, 2ˈ, 6ˈ, 7ˈ 
4ˈ - 147.5 - 2ˈ, 6ˈ, 7ˈ 
7ˈ 2.43 20.9 (+) 2ˈ, 3ˈ, 5ˈ, 6ˈ , 3ˈ, 4ˈ,5ˈ 
2″ 2.75 31.7 (+) - 2 
 
4F-PHP (2) 
 
 
 
 
 
 
1 - 195.3 - 2, 3, 2ˈ, 6ˈ 
2 5.66 67.4 (+) 3, 1″ 1, 3, 4 
3 * 1.82-2.03 29.3 ( ̶) 2, 4,5  1, 2, 4, 5 
4 ** 0.96-1.28 25.8( ̶) 3, 5, 6 2, 3, 5, 6 
5 ** 0.96-1.28 21.9 ( ̶) 3, 4, 6 3, 4, 6 
6 0.72 13.5 (+) 4, 5 4, 5 
1ˈ - 131.3 - 2ˈ, 3ˈ, 5ˈ, 6ˈ 
2ˈ, 6ˈ 8.21 132.1, 132.2 (+) 3ˈ, 5ˈ 1, 1ˈ, 3ˈ, 4ˈ, 5ˈ 
3ˈ, 5ˈ 7.47 116.4, 116.6 (+) 2ˈ, 6ˈ 1ˈ, 2ˈ,4ˈ, 6ˈ 
4ˈ - 164.7, 167.3 - 2ˈ,3ˈ, 5ˈ, 6ˈ  
2″,5″ 3.03-3.67 51.9, 53.7 ( ̶) 1″, 3″, 4″ 3″, 4″ 
3″, 4″ * 1.82-2.03 22.9 ( ̶) 2″, 5″ 2″, 5″ 
1″ (HCl salt) 10.81 - 2, 2″, 5″ - 
bk-EPDP (3)  
 
 
 
1 - 195.0 
 
- 2, 3, 2ˈ, 6ˈ 
2 5.04 61.6 (+) 3 1, 3, 4, 2″ 
3 1.92-1.98 32.5 ( ̶) 2, 4 1, 2, 4, 5 
4 * 1.12-1.35 17.1 ( ̶) 3, 5 2, 3, 5 
5 0.82 10.6 (+) 4 3, 4 
1ˈ - 127.6 - 2ˈ, 5 ˈ, 6ˈ 
2ˈ 7.42 108.5 (+) 6ˈ 1, 1ˈ, 3ˈ, 4ˈ, 6ˈ 
3ˈ - 148.3 - 2ˈ, 5ˈ, 8ˈ 
4ˈ - 153.6 - 2ˈ, 5ˈ, 6ˈ ,8ˈ 
5ˈ 6.98 107.8 (+) 6ˈ 1ˈ, 3ˈ, 4ˈ, 6ˈ 
6ˈ 7.66 126.5 (+) 2ˈ,5ˈ 1, 2ˈ, 4ˈ, 5ˈ 
8ˈ 6.09 102.6 (-) - 3ˈ, 4ˈ 
2″ 3.01-3.17 42.2 ( ̶) 3″ 2, 3″ 
3″ * 1.12-1.35 12.9 (+) 2″ 2″ 
*, ** = overlapped with each other in 1H;  + = DEPT positive signal;   ̶  =  DEPT negative signal. 
†the HMBC column lists either the C or the H(s) for the groups which show cross-peaks with the corresponding group (i.e. same row) in ID 
column  
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Table 2. HRMS analysis of cathinone samples. 
 
Chemical 
formula of 
[M+H]+ 
Exact mass 
[M+H]+ 
Accurate mass 
[M+H]+ 
Mass 
error 
(ppm) 
Observed fragment ions (m/z) 
Accurate 
mass 
Exact 
mass 
Mass 
error 
(ppm) 
Compound 1 
C13H20NO+ 
206.1539 206.1537 -0.97 
188.1431 
158.0963 
146.0963 
145.0885 
144.0806 
131.0728 
130.0650 
 
188.1434 
158.0964 
146.0964 
145.0886 
144.0808 
131.0730 
130.0651 
-1.59 
-0.63 
-0.68 
-0.69 
-1.39 
-1.53 
-0.77 
 
Compound 2 
C16H23FNO+ 
264.1758 264.1752 -2.27 
193.1022 
140.1432 
137.0396 
123.0239 
109.0447  
193.1023 
140.1434 
137.0397 
123.0241 
109.0448 
 
-0.52 
-1.43 
-0.73 
-1.63 
-0.92 
Compound 3  
C14H20NO3+ 
250.1438 250.1432 -2.40 
232.1327 
205.0855 
202.1223  
189.0781 
174.0549 
172.0756 
160.0755 
149.0231 
135.0438  
 
232.1332 
205.0859 
202.1226 
189.0784 
174.0550 
172.0757 
160.0757 
149.0233 
135.0441 
 
-2.15 
-1.95 
-1.48 
-1.59 
-0.57 
-0.58 
-1.25 
-1.34 
-2.22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



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